Livalo Tablet, Film Coated
Pricing Report NDC 66869-404-90

Current NADAC: $10.21756 per EA · Effective Aug 19, 2026 · Est. package price $919.58 (90 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Livalo (NDC 66869-404-90) is $10.21756 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Kowa Pharmaceuticals America, Inc., this medication is distributed in a 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$10.21756
Per EA

Effective Date
Aug 19, 2026
Billable Units
90 EA
Estimated Package Price
$919.58
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING
Generic Benchmark
The generic equivalent rate is $1.13620 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.85272 to $10.26295 per EA. Over this 12 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.8527 - $10.2630
Market Volatility
111.49% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $10.21756 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $10.21761 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $10.21824 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $10.21928 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $10.21539 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $10.21381 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $10.21035 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $10.22223 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $10.22783 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $10.22079 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $10.21585 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $10.21881 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026